Cargando…
Silymarin Administration Attenuates Cirrhotic-induced Cardiac Abnormality in the Rats: A Possible Role of β(1)-adrenergic Receptors and L-type Voltage-Dependent Calcium Channels
BACKGROUND: Cirrhotic cardiomyopathy is a well-recognized cardiac dysfunction in cirrhotic patients. Studies have confirmed the protective effects of silymarin in different types of cardiac injury. This study aimed to examine the effectiveness and molecular mechanism of silymarin against myocardial...
Autores principales: | Bayat, Gholamreza, Mazloom, Roham, Hashemi, Seyed Ali, Pourkhalili, Khalil, Fallah, Parviz, Shams, Alireza, Esmaeili, Parvaneh, Khalili, Azadeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339107/ https://www.ncbi.nlm.nih.gov/pubmed/35919076 http://dx.doi.org/10.30476/IJMS.2021.90750.2172 |
Ejemplares similares
-
Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
por: Jamshidi, Vahid, et al.
Publicado: (2021) -
New mechanistic insights into hepatoprotective activity of milk thistle and chicory quantified extract: The role of hepatic Farnesoid-X activated receptors
por: Khalili, Azadeh, et al.
Publicado: (2021) -
The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats
por: Ghobadi Pour, Mozhgan, et al.
Publicado: (2020) -
Immunomodulatory effects of silymarin after subacute exposure to mice: A tiered approach immunotoxicity screening
por: Karimi, Gholamreza, et al.
Publicado: (2018) -
Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
por: Khalili, Azadeh, et al.
Publicado: (2021)